DRUGS giant GlaxoSmithKline plans to narrow its research and could sell its rare diseases business as it steps up an efficiency drive under new chief executive, Emma Walmsley.
Source: Daily Express :: Finance Feed http://ift.tt/2va9z7z
Share this
Related Posts
Mistaken ID victim leads to credit nightmare and long battle to clear his name – Crusader
Will the ghost of mistaken debt markers keep haunting an innocent bank customer or will there be Christmas cheer as t- Carer’s Allowance to be replaced by 2026: Will you still be eligible?
THE CARER'S Allowance is due to be replaced by May 2026 to help more carers reach the support they need, but who will
- Savings update: Britons could secure 5% interest rate before Christmas - are you eligible?
THE LAST chance for Britons to stay above inflation has arrived just before Christmas, but who is eligible for the re
- Savings warning as Britons ‘woefully unprepared’ for retirement - you may need £250,000
A SAVINGS warning has been issued for Britons approaching their retirement, as many rely on their accounts but do not
EmoticonEmoticon